AVEO PHARMACEUTICALS INC - COM (AVEO)

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
42,798,755
Share change
-4,707,901
Total reported value
$36,170,822
Put/Call ratio
73%
Price per share
$0.84
Number of holders
58
Value change
-$3,555,594
Number of buys
22
Number of sells
33

Institutional Holders of AVEO PHARMACEUTICALS INC - COM (AVEO) as of Q3 2019

As of 30 Sep 2019, AVEO PHARMACEUTICALS INC - COM (AVEO) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,798,755 shares. The largest 10 holders included NEA Management Company, LLC, VANGUARD GROUP INC, BlackRock Inc., 683 Capital Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, X-Square Capital, LLC, WINTON GROUP Ltd, MILLENNIUM MANAGEMENT LLC, and Evercore Wealth Management, LLC. This page lists 58 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.